Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stents Versus PAclitaxel Coated Balloons for Revascularization of CompleX and Small Coronary Vessels (SPARX) Trial

NCT07397845 is registered in ClinicalTrials.gov with Translumina GmbH as lead sponsor.

NCT NCT07397845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07397845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stents Versus PAclitaxel Coated Balloons for Revascularization of CompleX and Small Coronary Vessels (SPARX) Trial
Lead sponsor
Translumina GmbH
Phase
Not applicable
Overall status
Recruiting
Start date
April 22, 2026
Completion date
April 30, 2029
Enrollment
1,380 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, drug eluting balloon, drug eluting stent